Literature DB >> 7705334

The AMP-activated protein kinase gene is highly expressed in rat skeletal muscle. Alternative splicing and tissue distribution of the mRNA.

A J Verhoeven1, A Woods, C H Brennan, S A Hawley, D G Hardie, J Scott, R K Beri, D Carling.   

Abstract

The AMP-activated protein kinase (AMPK) phosphorylates, and thereby inactivates, a number of enzymes involved in the regulation of lipid metabolism. We have studied the expression of the AMPK gene in a variety of rat tissues. The gene is transcribed into a message of approximately 9.5 kb as detected by Northern blotting. Highest expression of the AMPK message was found in skeletal muscle, which contained 20 amol/micrograms total RNA as determined by competitive reverse-transcription/polymerase chain reaction (RT-PCR). In liver, kidney, brain, mammary glands, heart and lung, AMPK mRNA levels ranged over 1-4 amol/micrograms total RNA. Adipose tissue contained less than 1 amol/microgram total RNA. A second AMPK mRNA form was detected by RT-PCR that was 142 bases shorter than the functional transcript. This transcript was apparently generated by alternative splicing of a single exon within the 5'-coding region. The shorter of the two messages, which is not translated into AMPK protein, contributed between 35-60% of AMPK mRNA in most tissues, but only 15-20% in skeletal muscle and heart. As a result, functional AMPK mRNA was sevenfold higher in skeletal muscle than in liver, although AMPK activity was much lower. By Western blotting, relatively large amounts of AMPK protein were detected in skeletal muscle compared to liver. AMPK isolated from skeletal muscle was not activated by treatment with AMPK kinase under conditions where liver AMPK was fully activated. A single 63-kDa polypeptide was immunoprecipitated from rat skeletal muscle using anti-peptide IgG against AMPK. In contrast, two additional polypeptides with apparent molecular masses of 38 kDa and 36 kDa co-precipitated with the 63-kDa AMPK protein from rat liver. These results indicate that the muscle enzyme has a different subunit organization compared to the liver enzyme, which may account for its low catalytic activity. Together, our results indicate a physiological role for AMPK in muscle, in addition to its previously described role in lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705334

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.

Authors:  P C Cheung; I P Salt; S P Davies; D G Hardie; D Carling
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  beta-subunits of Snf1 kinase are required for kinase function and substrate definition.

Authors:  M C Schmidt; R R McCartney
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

3.  Differential effects of PKA-controlled CaMKK2 variants on neuronal differentiation.

Authors:  Wenguang Cao; Muhammad Sohail; Guodong Liu; Geremy A Koumbadinga; Vincent G Lobo; Jiuyong Xie
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

4.  What is the functional role of the thalidomide binding protein cereblon?

Authors:  Xiu-Bao Chang; A Keith Stewart
Journal:  Int J Biochem Mol Biol       Date:  2011-09-10

5.  Cloning of human acetyl-CoA carboxylase-beta and its unique features.

Authors:  J Ha; J K Lee; K S Kim; L A Witters; K H Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  AMPK Prevents Palmitic Acid-Induced Apoptosis and Lipid Accumulation in Cardiomyocytes.

Authors:  Lucas Adrian; Matthias Lenski; Klaus Tödter; Jörg Heeren; Michael Böhm; Ulrich Laufs
Journal:  Lipids       Date:  2017-08-20       Impact factor: 1.880

7.  Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice.

Authors:  Curtis C Hughey; Freyja D James; Deanna P Bracy; E Patrick Donahue; Jamey D Young; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

Review 8.  Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance.

Authors:  Eijiro Yamada; Ting-Wen A Lee; Jeffrey E Pessin; Claire C Bastie
Journal:  Future Med Chem       Date:  2010-12       Impact factor: 3.808

9.  Effects of calcineurin activation on insulin-, AICAR- and contraction-induced glucose transport in skeletal muscle.

Authors:  Jeffrey W Ryder; Yun Chau Long; Elisabeth Nilsson; Margit Mahlapuu; Juleen R Zierath
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

10.  Effects of adrenaline on triacylglycerol synthesis and turnover in ventricular myocytes from adult rats.

Authors:  E M Swanton; E D Saggerson
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.